Zai Lab Limited (ZLAB), headquartered in Shanghai, China, is a leading biopharmaceutical company committed to advancing the discovery, development, and commercialization of innovative therapies for cancer, autoimmune disorders, and infectious diseases. The company boasts a compelling pipeline of drug candidates and strategically partners with global industry leaders to address significant unmet medical needs. With a strong emphasis on impactful research and development, Zai Lab is well-positioned to enhance patient outcomes and establish itself as a pivotal player in the evolving biopharmaceutical landscape. Show more

Location: BUILDING B, PUDONG, CHINA, 201203, Pudong, 201203, China | Website: https://www.zailaboratory.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

1.836B

52 Wk Range

$15.96 - $44.34

Previous Close

$16.60

Open

$16.27

Volume

1,417,101

Day Range

$15.96 - $16.45

Enterprise Value

17.86B

Cash

717.2M

Avg Qtr Burn

-32.04M

Insider Ownership

1.80%

Institutional Own.

34.74%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Zocilurtatug pelitecan (formerly ZL-1310) Details 2L relapsed small cell lung cancer (SCLC)	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Zocilurtatug pelitecan (formerly ZL-1310) Details Neuroendocrine carcinoma	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Zocilurtatug pelitecan (formerly ZL-1310) Details Extensive-Stage Small Cell Lung Cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ZL-1503 Details Moderate-to-severe atopic dermatitis	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.